Company / Cost of Revenue
iRhythm Holdings, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$219.9M
FY2025
5-year range
$109.3M / $219.9M
FY2021-FY2025
Trend
+19.3%
vs FY2024
Sector context
#74 of 107
Health Care
What the data says
At $220M, iRhythm Holdings, Inc.'s cost of revenue ranks #34 of 107 in the Health Care sector. Cost of Revenue has increased for 9 consecutive years, from $21M in FY2016 to $220M in FY2025.
Based on SEC 10-K filings.
$220M in FY2025 with a 5-year CAGR of +25.6%.
Increased from $161M to $220M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +19.4%
- 5-Year CAGR
- +25.6%
- 10-Year CAGR
- -
Sector benchmark
#34 of 107 in Health CareTop 31% of 107This company $219.9M Sector average $11.8B
▼
-98.1% below sector average
Key checks
Key Insights
- iRhythm Holdings, Inc.'s cost of revenue has grown for 9 consecutive years.
- 5-year CAGR of +25.6%, indicating consistent growth.
- In FY2025, cost of revenue increased 19.3% year-over-year.
- Ranks #74 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- Negative profit margin: -19.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $219.9M | +19.3% |
| FY2024 | $184.3M | +14.6% |
| FY2023 | $160.9M | +24.4% |
| FY2022 | $129.3M | +18.3% |
| FY2021 | $109.3M | +55.5% |
| FY2020 | $70.3M | +33.9% |
| FY2019 | $52.5M | +35.3% |
| FY2018 | $38.8M | +37.6% |
| FY2017 | $28.2M | +35.1% |
| FY2016 | $20.9M | +42.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026